Lymphoma in Patients with Rheumatoid Arthritis
- 1 January 1999
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 20 (6), 475-487
- https://doi.org/10.2165/00002018-199920060-00002
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Methotrexate in Rheumatoid ArthritisDrugs, 1994
- CD5+ B cells in autoimmune disease and lymphoid malignancyClinical Immunology and Immunopathology, 1991
- Methyl-acetylenicputrescine (MAP), an inhibitor of polyamine biosynthesis, reduces the frequency and cytolytic activity of alloantigen-induced lyt 2.2 positive lymphocytes in vivoInternational Journal of Immunopharmacology, 1989
- Factors influencing mortality in rheumatoid arthritisJournal of Chronic Diseases, 1986
- No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic TumorsThe New England Journal of Medicine, 1983
- Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritisJournal of Chronic Diseases, 1978
- Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative SyndromeThe New England Journal of Medicine, 1977
- Life-span carcinogenicity tests with 4-amino-N10-methylpteroylglutamic acid (methotrexate) in Swiss mice and Syrian golden hamstersToxicology and Applied Pharmacology, 1973
- Human mitotic and meiotic chromosome damage following in vivo exposure to methotrexateClinical Genetics, 1971
- CHROMOSOMAL ABNORMALITIES PRODUCED BY FOLIC ACID ANTAGONISTS.British Journal of Dermatology, 1965